Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 118363
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118363
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118363
Table 1 Baseline characteristics of study population, n (%)/mean ± SD
| Parameter | Value |
| Number of patients | 69 |
| Mean age, years | 51.6 ± 11.6 |
| Male:female ratio | 4.75:1 |
| Mean BMI | 25.4 ± 2.7 |
| Diabetes mellitus | 25 (36.2) |
| Hypertension | 35 (50.7) |
| Coronary artery disease | 25 (36.2) |
| Smoking | 11 (15.9) |
| Alcohol use | 6 (8.7) |
| Mean hemoglobin, g/dL | 8.8 ± 1.4 |
| Raised triglycerides (> 200 mg/dL) | 7 (10.1) |
| Abnormal vessel histology | 34 (49.3) |
| Radio-cephalic AVF | 46 (66.7) |
| Brachio-cephalic AVF | 21 (30.4) |
| Brachio-basilic AVF | 2 (2.9) |
Table 2 Factors associated with patency of arterio-venous fistula 6 weeks after surgery, on univariate and multivariate analysis, n (%)/mean ± SD
| Univariate analysis | Multivariate analysis | |||||||
| Variables | AVF patency at 6 weeks | No | Yes | P value | Odds ratio | 95%CI | P value | |
| Triglycerides | < 200 mg/dL | 4 (5.80) | 3 (4.30) | 0.036 | 0.162 | 0.032 | 0.828 | 0.029 |
| > 200 mg/dL | 11 (15.90) | 51 (73.90) | ||||||
| Vessel wall biopsy | Normal | 0 (0.00) | 31 (44.90) | < 0.0001 | 1.652 | 1.278 | 2.136 | 0.001 |
| Abnormal | 15 (21.70) | 23 (33.30) | ||||||
| Artery diameter (mm) | 2.73 ± 0.97 | 3.52 ± 1.33 | 0.036 | 1.488 | 0.469 | 4.721 | 0.026 | |
| Vein diameter (mm) | 2.75 ± 0.89 | 3.72 ± 1.12 | 0.003 | 1.677 | 0.431 | 2.457 | 0.041 | |
| Depth of artery from skin (mm) | 4.81 ± 2.50 | 2.93 ± 2.05 | 0.01 | 2.633 | 1.254 | 4.379 | 0.015 | |
| Depth of vein from skin (mm) | 2.82 ± 1.01 | 2.15 ± 0.95 | 0.02 | 1.869 | 0.852 | 2.736 | 0.026 | |
Table 3 Factors associated with maturity of arterio-venous fistula 12 weeks after surgery, on univariate and multivariate analysis, n (%)/mean ± SD
| Univariate analysis | Multivariate analysis | |||||||
| Variables | AVF patency at 6 weeks | No | Yes | P value | Odds ratio | 95%CI | P value | |
| Smoking | Yes | 14 (20.30) | 44 (63.80) | 0.016 | 2.759 | 1.656 | 5.877 | 0.03 |
| No | 0 (0.00) | 11 (15.90) | ||||||
| Triglycerides | < 200 mg/dL | 4 (5.80) | 3 (4.30) | 0.027 | 0.144 | 0.028 | 0.746 | 0.021 |
| > 200 mg/dL | 10 (14.50) | 52 (75.40) | ||||||
| Vessel wall biopsy | Normal | 0 (0.00) | 31 (44.90) | 0.0001 | 1.583 | 1.242 | 2.019 | 0.001 |
| Abnormal | 14 (20.30) | 24 (34.80) | ||||||
| Artery diameter (mm) | 2.57 ± 0.77 | 3.55 ± 1.33 | 0.011 | 1.751 | 0.536 | 5.712 | 0.031 | |
| Vein diameter (mm) | 2.70 ± 0.90 | 3.71 ± 0.90 | 0.002 | 2.557 | 1.145 | 3.891 | 0.032 | |
| Depth of artery from skin (mm) | 4.91 ± 0.51 | 2.43 ± 0.51 | 0.0001 | 0.532 | 0.11 | 1.967 | 0.001 | |
| Depth of vein from skin (mm) | 2.87 ± 0.90 | 2.15 ± 0.94 | 0.014 | 0.856 | 0.214 | 1.95 | 0.036 | |
Table 4 Postoperative complications at 1 week
| Complication | Incidence (%) | Associated factors |
| Surgical site infection | 10.1 | Age > 60, Alcohol use, low high-density lipoprotein |
| Bleeding | 8.7 | High triglycerides, abnormal morphology, smaller artery, greater depth |
Table 5 Arteriovenous fistula patency and maturation at follow-up
| Follow-up time | AVF patent (%) | AVF matured (%) | Independent predictors |
| 1 week | 79.7 | N/A | Depth, triglycerides, histology |
| 6 weeks | 78.3 | 66.7 | Triglycerides, smoking, histology, vessel size |
| 12 weeks | 73.9 | 79.7 | Triglycerides, smoking, histology, vessel size |
Table 6 Independent predictors of poor arteriovenous fistula outcomes
| Parameter | Odds ratio | P value |
| Raised triglycerides | 0.144 | 0.021 |
| Smoking | 2.759 | 0.03 |
| Abnormal vessel histology | 1.583 | 0.0001 |
| Arterial diameter (larger) | 1.751 | 0.031 |
| Venous diameter (larger) | 2.557 | 0.032 |
| Arterial depth (superficial) | 0.532 | 0.001 |
| Venous depth (superficial) | 0.856 | 0.036 |
- Citation: Gupta S, Hegde AV, Shetty S, Michael SN, Adiga K P. Can preoperative parameters and histopathology of the vessels affect arteriovenous fistula outcomes? A prospective observational study. World J Nephrol 2026; 15(2): 118363
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/118363.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.118363